Early intervention in pertussis outbreak with high attack rate in cohort of adolescents with complete acellular pertussis vaccination in Valencia, Spain, April to May 2015

Eurosurveillance

Volumn 20, Issue 27, 2015, Pages 1-4

  Miguez Santiyan A ^a   Ferrer Estrems, R ^b   Chover Lara, J L ^a   Alberola Enguidanos J ^c   Nogueira Coito, J M ^c   Salazar Cifre, A ^a  

^a Public Health Centre of Valencia   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; PERTUSSIS VACCINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BIOLOGICAL ACCIDENT; EARLY INTERVENTION; HUMAN; INCIDENCE; INTERVIEW; PERTUSSIS; PREGNANT WOMAN; PRIMARY HEALTH CARE; RISK ASSESSMENT; SPAIN; VACCINATION; ADOLESCENT; ADULT; CHILD; EPIDEMIC; FEMALE; INFECTION CONTROL; MALE; ORGANIZATION AND MANAGEMENT; SCHOOL; STATISTICS AND NUMERICAL DATA; TRANSMISSION; WHOOPING COUGH;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; INFECTION CONTROL; MALE; PERTUSSIS VACCINE; SCHOOLS; SPAIN; VACCINATION; WHOOPING COUGH;

EID: 84937196367     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2015.20.27.21183     Document Type: Article

References (16)

1. Generalitat Valenciana. Conselleria de Sanitat. Dirección General de Salud Pública. [General Directorate of Public Health]. Valencia: Generalitat Valenciana. [Accessed 9 Jul 2015]. Spanish. Available from: http://www.sp.san.gva.es
2. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Red Nacional de Vigilancia Epidemiológica. Protocolos de enfermedades de declaración obligatoria. [Protocol for diseases with mandatory notification]. Madrid, 2013. [Accessed 9 Jul 2015]. Spanish. Available from: http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/PROTOCOLOS_RENAVE.pdf
3. World Health Organization (WHO). WHO SAGE pertussis working group. Background paper. SAGE April 2014. Geneva: WHO. [Accessed 9 Jul 2015]. Available from: http://www.who.int/immunization/sage/meetings/2014/april/1_Pertussis_background_FINAL4_web.pdf
4. Sizaire V, Garrido-Estepa M, Masa-Calles J, Martínez de Aragon MV. Increase of pertussis incidence in 2010 to 2012 after 12 years of low circulation in Spain. Euro Surveill. 2014;19(32):20875. http://dx.doi.org/10.2807/1560-7917. ES2014.19.32.20875 PMID:25139074
5. Aase A, Herstad TK, Jørgensen SB, Leegaard TM, Berbers G, Steinbakk M, et al. Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of age. Vaccine. 2014;32(45):5931-6. http://dx.doi.org/10.1016/j.vaccine.2014.08.069 PMID:25218299
6. Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54(12):1730-5. http://dx.doi.org/10.1093/cid/cis287PMID:22423127
7. Aizpurua P, Rivas MA. ¿Hay relación entre los últimos brotes de tosferina y el uso de vacuna acelular? [Is there any connection between the recent pertussis outbreaks and the use of acellular vaccine?]. Evid Pediatr. 2013;9:69. Spanish.
8. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA. 2012;308(5):454-6. http://dx.doi.org/10.1001/jama.2012.6364 PMID:22851107
9. Moreno-Pérez D, Álvarez García FJ, Arístegui Fernández J, Cilleruelo Ortega MJ, Corretger Rauet JM, García Sánchez N, et al.; en representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP). [Immunisation schedule of the Spanish Association of Paediatrics: 2015 recommendations]. An Pediatr (Barc). 2015;82(1):44.e1-12.PMID:25554656
10. Generalitat Valenciana. Dirección General de Salud Pública. Subdirección general de epidemiología y vigilancia de la salud. Servicio de Vigilancia y Control Epidemiológico. Tos ferina. Vigilancia Epidemiológica año 2011. [Whooping cough. Epidemiological surveillance 2011]. Spanish. Available from: http://www.sp.san.gva.es/DgspPortal/docs/Tosferina_2011.pdf
11. Generalitat Valenciana. Conselleria de Sanitat. Dirección General de Salud Pública. Subdirección general de epidemiología y vigilancia de la salud. Análisis epidemiológico semanal. [Weekly epidemiological analysis]. Spanish. Available from: http://www.sp.san.gva.es/DgspPortal/docs/semana_cas.pdf
12. Wang K, Fry NK, Campbell H, Amirthalingam G, Harrison TG, Mant D et al, Whooping cough in school age children presenting with persistent cough in UK primary care after introduction of the preschool pertussis booster vaccination: prospective cohort study. BMJ. 2014;348:g3668foi:10.1136/bmj.g3668
13. Amirthalingam G, Andrews N, Campbell H, Riberior S, Kara E, Donegan K et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 384:1521-1528. Oct 25.2014.
14. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis. 2007;7(9):614-24. http://dx.doi.org/10.1016/S1473-3099(07)70113-5 PMID:17537674
15. Amirthalingam G. Strategies to control pertussis in infants. Arch Dis Child. 2013;98(7):552-5. http://dx.doi.org/10.1136/archdischild-2012-302968 PMID:23698594
16. Dirección General de Salud Pública. Conselleria de Sanitat. Generalitat Valenciana. Vacunación de las embarazadas frente a la tos ferina en la Comunidad Valenciana. [Vaccination of pregnant women against pertussis in Valencian Community]. Spanish. Available from: http://www.sp.san.gva.es/DgspPortal/docs/VACUNACION_DE_LAS_EMBARAZADAS_FRENTE_TOS_FERINA_CCVV.pdf